Minodronic acid monohydrate is a third-generation bisphosphonate mainly used for the treatment and prevention of osteoporosis. It is specifically used in postmenopausal women and men at high risk of fractures. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Recalbon (TN) and Bonoteo (TN). Its PubChem CID is 23201029.
Minodronic acid monohydrate
| CAS No | 155648-60-5 |
|---|---|
| Molecular Formula | C9H14N2O8P2 |
| Molecular Weight | 340.16 g/mol |
| Synonyms | (1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Minodronic acid monohydrate is a third-generation bisphosphonate mainly used for the treatment and prevention of osteoporosis. It is specifically used in postmenopausal women and men at high risk of fractures.
The listed CAS number is 155648-60-5.
The listed molecular formula is C9H14N2O8P2.
The listed molecular weight is 340.16 g/mol.
(1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid;hydrate.
The source lists Recalbon (TN) and Bonoteo (TN).